Jillella, A P <br/><br/>
High-dose chemotherapy followed by reinfusion of a high number of CD34+ progenitor cells is frequently associated with development of fever in the postengraftment period.  [electronic resource] 

 -  Journal of hematotherapy & stem cell research  Dec 2000 
 - 849-54 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1525-8165 
<br/><br/><label>Standard No.: </label>10.1089/152581600750062273  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antigens, CD34--blood<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--complications<br/>Female<br/>Fever--etiology<br/>Graft vs Host Disease--etiology<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Hematopoietic Stem Cells--immunology<br/>Humans<br/>Middle Aged<br/>Neoplasms--complications<br/>Odds Ratio<br/>Retrospective Studies<br/>Sex Factors<br/>Transplantation, Autologous